Border Medical Oncology

East Albury 2640

0 studies enrolling now · 4 studies all time

What they study most

Carcinoma, Pancreatic Ductal, Indolent Systemic Mastocytosis, Melanoma Stage III, Melanoma Stage IV, Metastatic Prostate Cancer, Myelofibrosis, Unresectable Melanoma

Studies at this site

• A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment — Completed
• Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis — Status unconfirmed
• A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer — Completed
• A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma — Completed